| Not Yet Recruiting | Congenital Heart Diseases and Developmental Assessment in Cholestatic Infants Under Two Years NCT07247604 | Assiut University | — |
| Active Not Recruiting | PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobilia NCT06604923 | University of Aarhus | — |
| Enrolling By Invitation | PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in P NCT06610695 | University of Aarhus | — |
| Not Yet Recruiting | Investigation of the Pruritogens of Liver-related Diseases NCT06364969 | Peking University | — |
| Unknown | Mallampati Score for Prediction and Prognosis of Postoperative Mortality and Morbidity and Safety Profiles of NCT06005701 | Qassim University | — |
| Completed | Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis NCT04604652 | HighTide Biopharma Pty Ltd | Phase 2 |
| Unknown | Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Urso NCT04309773 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic NCT04510090 | Escient Pharmaceuticals, Inc | Phase 1 |
| Active Not Recruiting | Linerixibat Long-term Safety, and Tolerability Study NCT04167358 | GlaxoSmithKline | Phase 3 |
| Completed | Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects NCT04053023 | GlaxoSmithKline | Phase 1 |
| Completed | Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat NCT03992014 | GlaxoSmithKline | Phase 1 |
| Completed | Omegaven as Alternative Parenteral Fat Nutrition NCT03662282 | University of South Florida | Phase 3 |
| Active Not Recruiting | Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease NCT05582447 | Children's Hospital Medical Center, Cincinnati | — |
| Unknown | Paternally Inherited Phenotypes in Cholestasis NCT03337074 | Guy's and St Thomas' NHS Foundation Trust | — |
| Completed | Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangit NCT02966834 | GlaxoSmithKline | Phase 2 |
| Unknown | FGF19 in Obstructive Cholestasis: "Unveil the Signal" NCT05718349 | Nicole Hildebrand | — |
| Unknown | Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome NCT02936596 | Xiaoli Fan | N/A |
| Completed | FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) NCT02922751 | Arbor Research Collaborative for Health | — |
| Completed | Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital NCT02917408 | Xiaoli Fan | — |
| Completed | Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers NCT02801981 | GlaxoSmithKline | Phase 1 |
| Withdrawn | Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in In NCT02420496 | The University of Texas Health Science Center at San Antonio | Phase 2 |
| Completed | Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD NCT02357576 | University of Michigan | Phase 3 |
| Terminated | SMOFlipid to Lessen the Severity of Neonatal Cholestasis NCT02721277 | University of Florida | Phase 1 / Phase 2 |
| Completed | Compassionate Use of Omegaven in Children NCT02370251 | University of Oklahoma | Phase 2 / Phase 3 |
| Terminated | Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancr NCT02267707 | Celgene | Phase 1 |
| Completed | Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition NCT02663453 | Thammasat University | Phase 3 |
| Unknown | Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis NCT01998620 | Zhejiang Hisun Pharmaceutical Co. Ltd. | Phase 4 |
| Unknown | Omegaven® as Parenteral Nutrition NCT02334293 | Carle Foundation Hospital | N/A |
| Completed | Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT NCT01879735 | University of Aarhus | Phase 1 |
| Completed | Preventing Cholestasis Using SMOFLipid® NCT01585935 | Medical University of Vienna | Phase 4 |
| Completed | Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall S NCT01683240 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Terminated | Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders NCT01373918 | University of California, Los Angeles | Phase 4 |
| Unknown | Minimization of IntraLipid Versus Omegaven NCT01247012 | Children's & Women's Health Centre of British Columbia | Phase 2 / Phase 3 |
| Completed | Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children NCT01194063 | Kapiolani Medical Center For Women & Children | Phase 3 |
| Unknown | Retrospective Review of CT and MR in Pediatric Patients With Cholestasis NCT01252043 | National Taiwan University Hospital | — |
| Completed | Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis NCT01173159 | Children's Hospital Medical Center, Cincinnati | N/A |
| Terminated | Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region NCT02767648 | University Hospital, Toulouse | — |
| Completed | Cholestasis in Extreme Low Birth Weight Infants (ELBW) NCT01164878 | Medical University of Vienna | — |
| Terminated | A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease NCT00969332 | University of California, Los Angeles | Phase 2 |
| Completed | Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholest NCT00826020 | University of Nebraska | Phase 2 |
| Unknown | Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver NCT01739517 | Amarnath, Rathna, M.D. | Phase 2 |
| Terminated | Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants NCT01062815 | University of Miami | N/A |
| Terminated | Compassionate Use of Omegaven IV Fat Emulsion NCT00816348 | Cindy Haller | Phase 2 |
| Completed | Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates NCT00846963 | Ibrahim Mohamed | Phase 2 / Phase 3 |
| Completed | Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants NCT00738101 | Baylor College of Medicine | N/A |
| Completed | A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cho NCT00685386 | University of North Carolina, Chapel Hill | N/A |
| Completed | Cholestasis Prevention: Efficacy of IV Fish Oil NCT00512629 | Boston Children's Hospital | Phase 1 |
| Completed | Brain Manganese Deposition in High Risk Neonates NCT00392977 | Vanderbilt University | — |
| Completed | Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children NCT00392730 | Vanderbilt University | — |
| Unknown | A Trial of Taurine Supplementation in Parenteral Nutrition 1 NCT00135044 | London North West Healthcare NHS Trust | N/A |
| Completed | Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation NCT01073202 | Shanghai Jiao Tong University School of Medicine | N/A |
| Completed | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation NCT00080236 | Conatus Pharmaceuticals Inc. | Phase 2 |
| Completed | Gabapentin to Treat Itch in Patients With Liver Disease NCT00058890 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Diseas NCT00007033 | National Center for Research Resources (NCRR) | N/A |
| Completed | Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated NCT00004410 | Children's Hospital Medical Center, Cincinnati | N/A |
| Completed | Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutr NCT00004414 | University of Michigan | N/A |
| Unknown | Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursod NCT00004315 | National Center for Research Resources (NCRR) | Phase 2 |
| Completed | Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid NCT00007020 | Mirum Pharmaceuticals, Inc. | Phase 3 |
| Approved For Marketing | Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease NCT01297933 | Children's Hospital of Philadelphia | — |
| No Longer Available | Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis NCT02148146 | University of California, San Diego | — |
| Approved For Marketing | Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury NCT02780193 | Rush University Medical Center | — |
| Approved For Marketing | Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease NCT03072667 | Catherine Cibulskis, MD | — |
| Approved For Marketing | Compassionate Use of Omegaven NCT02778698 | Geisinger Clinic | — |
| Approved For Marketing | SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury NCT02412566 | Baylor College of Medicine | — |
| No Longer Available | Compassionate Use of Omegaven IV Fat Emulsion NCT02477345 | Northwell Health | — |